Yüklüyor......
Raloxifene. Not better than estrogen.
Raloxifene is marketed in France for prevention of nontraumatic vertebral fracture in postmenopausal women. In animal pharmacology studies, it was found to both agonize and antagonize estrogen. The assessment file is methodologically sound but fails to answer many practical questions. A placebo-cont...
Kaydedildi:
| Materyal Türü: | Artigo |
|---|---|
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
College of Family Physicians of Canada
2000
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2144789/ https://ncbi.nlm.nih.gov/pubmed/10955178 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|